Original Research
Published on 31 Oct 2023
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System
in Gastrointestinal Cancers: Colorectal Cancer
- 3,152 views
- 7 citations